Article Versions Notes

Risinskaya N, Kozhevnikova Y, Gavrilina O, Chabaeva J, Kotova E, Yushkova A, Isinova G, Zarubina K, Obukhova T, Kulikov S, et al. Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL. Genes. 2022; 13(3):398. https://doi.org/10.3390/genes13030398

Risinskaya, Natalya, Yana Kozhevnikova, Olga Gavrilina, Julia Chabaeva, Ekaterina Kotova, Anna Yushkova, Galina Isinova, Ksenija Zarubina, Tatiana Obukhova, Sergey Kulikov, and et al. 2022. "Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL" Genes 13, no. 3: 398. https://doi.org/10.3390/genes13030398

Risinskaya, N., Kozhevnikova, Y., Gavrilina, O., Chabaeva, J., Kotova, E., Yushkova, A., Isinova, G., Zarubina, K., Obukhova, T., Kulikov, S., Julhakyan, H., Sudarikov, A., & Parovichnikova, E. (2022). Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL. Genes, 13(3), 398. https://doi.org/10.3390/genes13030398